Primary central nervous system lymphoma surgery

• Diffusion-weighted imaging and susceptibility-weighted imaging in differentiating ring-enhancing primary central nervous system lymphoma from infections
• Monomorphic epitheliotropic intestinal T-cell lymphoma with gallbladder involvement: A case report
• A Case of Primary Central Nervous System T-cell Lymphoma of the Spinal Cord Detected by 18F-FDG PET/CT
• Single-cell and spatial characterization of plasmablast-like lymphoma cells in primary central nervous system lymphoma
• Complex Differential Diagnosis Between Cerebral Toxoplasmosis and Primary CNS Lymphoma in Immunocompromised Patients: The Value of Brain Biopsy
• Primary Vitreoretinal Lymphomas: A Diagnostic Challenge - Report of Two Recent Cases with Retinal Biopsies and Molecular Investigations in Halifax, Nova Scotia
• Metabolic pathway alterations in cerebrospinal fluid as diagnostic biomarkers for primary central nervous system lymphoma
• A response of rituximab plus lenalidomide therapy in patients with post-transplant lymphoproliferative disease and methotrexate-related lymphoproliferative disorder in the central nervous system: a case report

Surgical decompression with partial or gross total resection does not alter patient’s prognosis.

The main indication for surgery:

Biopsy: obtain solid tissue to ascertain that the tumor is lymphoma, and to determine the type of lymphoma. Stereotactic techniques are often well-suited for these often deep tumors ¹⁾

Although few data are available in the scientific literature, surgery has traditionally been deemed to have no role in the treatment of primary central nervous system lymphoma. This widely adopted opinion is based on small retrospective series, the results of which suggest no clear benefits in the outcome of surgical resection when used as a sole treatment, compared with supportive care (class IIIb) ²⁾ and compared with evidence from biopsy samples from patients who received postoperative chemotherapy or radiotherapy (class IIIb) ^{3) 4)}.

The absence of surgical effectiveness might be attributable to the microscopic, multifocal, and infiltrative nature of primary CNS lymphoma that can extend beyond the visible border of the lesion ⁵⁾. The high radiosensitivity and chemosensitivity of primary CNS lymphoma, and the risk of postoperative morbidity in this patient population, have likewise helped discourage surgery. However, the recommendation to restrict surgical interventions to biopsies is not based on randomised data and, more importantly, not on contemporary data based on modern neurosurgical techniques. The German Primary CNS Lymphoma Study Group-1 (G-PCNSL-SG-1) phase 3 trial ⁶⁾ included an unusually high proportion of operated patients, which allowed a large retrospective analysis of the association of surgery and expected outcome. Patients with subtotal or total resections had significantly longer progression-free survival and overall survival than did patients who received biopsies. This difference in outcome was independent of the postoperative Karnofsky Performance Score and age. Since patients who had a biopsy more often had many deeply-seated CNS lesions than patients who received surgery, this difference might have contributed to the unfavourable outcomes in the patients who had biopsies. When adjusted for the number of lesions (depth of lesions was not analysed in the study), the difference in outcome remained statistically significant for progression free survival, but not for overall survival (class 3a study) ⁷⁾.

To rapidly reduce intracranial pressure, surgical resection can be undertaken in patients with large lesions and acute symptoms of brain herniation (good practice point).

In patients suspected of primary central nervous system lymphoma with a unifocal and resectable lesion, the panel did not establish consensus about whether to recommend surgical resection or the need for tissue biopsy ⁸⁾.